You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • THU0186 Safety of Tofacitinib Compared to Biological Disease Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients with an Inadequate Response to Methotrexate: Overview of Systematic Review

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - non biologic treatment and small molecules
THU0186 Safety of Tofacitinib Compared to Biological Disease Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients with an Inadequate Response to Methotrexate: Overview of Systematic Review

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 20151700
Jul 20151201
Aug 20151602
Sep 20152801
Oct 2015901
Nov 20151603
Dec 20152105
Jan 20163206
Feb 20162101
Mar 20163702
Apr 20162602
May 20162301
Jun 20163204
Jul 20161700
Aug 201648018
Sep 20161200
Oct 20161602
Nov 20162102
Dec 20161600
Jan 20171100
Feb 20171403
Mar 20172506
Apr 20171001
May 20175602
Jun 20172501
Jul 20172803
Aug 20173000
Sep 20172000
Oct 20173600
Nov 20173400
Dec 20172200
Jan 20184802
Feb 20181400
Mar 20181801
Apr 20182802
May 20182200
Jun 20182600
Jul 20182400
Aug 20181000
Sep 2018400
Oct 2018401
Nov 20183004
Dec 2018400
Jan 20191800
Feb 20192803
Mar 20191100
Apr 2019400
May 20191100
Jun 2019600
Jul 20195200
Aug 20195401
Sep 20191602
Oct 20191001
Nov 20191100
Dec 20193301
Jan 2020700
Feb 20201700
Mar 20203303
Apr 20201400
May 2020600
Jun 20201400
Jul 20202301
Aug 20201900
Sep 20201400
Oct 2020600
Nov 2020700
Dec 2020800
Jan 2021802
Feb 2021800
Mar 20211200
May 2021900
Jun 2021500
Aug 2021100
Oct 2021400
Nov 2021800
Dec 20211000
Jan 20222000
Feb 20221000
Mar 2022200
Apr 2022200
May 20221700
Jun 2022600
Jul 20221300
Aug 20222400
Sep 2022300
Oct 2022200
Nov 2022700
Dec 20221601
Jan 2023200
Feb 20231601
Mar 2023200
May 2023200
Jul 2023200
Sep 2023600
Oct 2023200
Dec 20231000
Jan 2024200
Feb 2024200
Mar 2024200
Total1620093